Show notes
Did you know there's a brand new neurotoxin poised to come to market? Did you know that Allergan snapped up the small biotech company for $195M as soon as their phase 2 clinical trial results were released? Join us in this episode as we explore the personality and behavior of the latest botulinum toxin to join the Botox Party!
https://www.marketwatch.com/story/allergan-will-buy-neurotoxin-company-bonti-for-195-mln-2018-09-14